Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02435849
Title Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients
Acronym ELIANA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | NOR | ITA | FRA | ESP | DEU | CAN | BEL | AUT | AUS


No variant requirements are available.